ArticleHeliyon2023

Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients.

Jiannan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.